Stay updated on Clinical Trial: Higher Dose BGB324 in Lung Cancer
Sign up to get notified when there's something new on the Clinical Trial: Higher Dose BGB324 in Lung Cancer page.

Latest updates to the Clinical Trial: Higher Dose BGB324 in Lung Cancer page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe 403 error page is replaced by the ClinicalTrials.gov record for the BGB324 and docetaxel lung cancer study, displaying its study details and protocol document.SummaryDifference46%

- Check14 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide notice says NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check28 days agoChange DetectedThe site footer’s revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the expected study details and navigation, indicating an access problem that prevents viewing the trial information.SummaryDifference18%

Stay in the know with updates to Clinical Trial: Higher Dose BGB324 in Lung Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Higher Dose BGB324 in Lung Cancer page.